Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy - 30/09/22
, Paolo Belli a, b, Anna Rita Scrofani a, b, Federica Petta a, b, Alberto Borghetti c, Fabio Marazzi d, Vincenzo Valentini d, Riccardo Manfredi a, b
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Highlights |
• | Background parenchymal enhancement (BPE) is the enhancement of breast tissue on MR imaging. |
• | BPE is not associated with outcome in patients with breast cancer treated with neoadjuvant chemotherapy (NAC). |
• | In the NAC setting, BPE provides less information than tumor proliferation activity, type of surgery and nodal involvement. |
Abstract |
Purpose |
The purpose of this study was to retrospectively investigate whether background parenchymal enhancement (BPE) of the contralateral breast on magnetic resonance imaging (MRI) is associated with clinical outcomes in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy (NAC).
Materials and methods |
A total of 228 women (47.6 years ± 10 [SD]; range: 24–74 years) with invasive breast cancer who underwent NAC between 2005 and 2013 were included. All included patients underwent breast MRI before and after NAC. Quantitative semiautomated analysis of BPE of the contralateral healthy breast was performed. The enhancement level on baseline MRI (baseline BPE) and on MRI after chemotherapy (final BPE) and the change in enhancement rate between baseline MRI and final MRI were recorded. Cox regression was used to test associations between BPE variables, patient and tumor characteristics, overall survival (OS) and disease–free survival (DFS). Subgroup analyses based on menopausal status and immunohistochemical subtypes were performed.
Results |
Median follow-up was 92 months. Multivariable analysis revealed that Ki-67 level (P = 0.026) and receipt of mastectomy (P = 0.015) were independent variables associated with OS while Ki-67 level (P = 0.010) and post-NAC pathological node categorization (P = 0.027) were independent variables associated with DFS. BPE was not associated with OS (P = 0.500, 0.546 and 0.712 for baseline BPE, final BPE and BPE change, respectively) or with DFS (P = 0.568, 0.412 and 0.327, respectively).
Conclusion |
BPE of the contralateral breast on MRI may have limited prognostic value in patients with breast cancer treated with NAC.
El texto completo de este artículo está disponible en PDF.Keywords : Breast neoplasms, Magnetic resonance imaging, Neoadjuvant therapy, Disease-free survival, Prognosis
Abbreviations : BPE, CI, CM, DFS, HER2, HR, FISH, IHC, MRI, NAC, OS, pCR, ROI, TILs
Esquema
Vol 103 - N° 10
P. 486-494 - octobre 2022 Regresar al número
Artículo precedente
- Fast T2-weighted liver MRI: Image quality and solid focal lesions conspicuity using a deep learning accelerated single breath-hold HASTE fat-suppressed sequence
- Sébastien Mulé, Rym Kharrat, Pierre Zerbib, Aurélien Massire, Marcel Dominik Nickel, Khalid Ambarki, Edouard Reizine, Laurence Baranes, Benhalima Zegai, Frederic Pigneur, Hicham Kobeiter, Alain Luciani
- Transnasal approach for first cervical vertebra (C1) lateral mass cementoplasty
- Idriss Haffaf, Bertrand Baujat, Matthias Barral
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.